RECRUITING

Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue

Conditions

Liver Transplant Living Donor Liver Transplant Liver Transplant Complications

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.

Official Title

Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue: A Prospective Non-Randomized Clinical Trial

Quick Facts

Study Start:2024-10-29

Study Completion:2027-07

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT07102550

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Adults \>/= 18 years old * Recipient of LDLT	* Patients who are deemed unsafe for participation for any reason by our multi-disciplinary liver transplant selection committee. * Patients \< 18 years old * Patients who cannot provide informed consent * Patients receiving deceased donor liver transplants, or who are not undergoing Liver transplant (LT) * Patients who do not wish to participate * Children, cognitively-impaired persons, pregnant women, students and house staff under the direct supervision of the investigator are considered vulnerable populations and will, therefore, be excluded from participation.

Inclusion Criteria

Exclusion Criteria

* Adults \>/= 18 years old
* Recipient of LDLT

* Patients who are deemed unsafe for participation for any reason by our multi-disciplinary liver transplant selection committee.
* Patients \< 18 years old
* Patients who cannot provide informed consent
* Patients receiving deceased donor liver transplants, or who are not undergoing Liver transplant (LT)
* Patients who do not wish to participate
* Children, cognitively-impaired persons, pregnant women, students and house staff under the direct supervision of the investigator are considered vulnerable populations and will, therefore, be excluded from participation.

Contacts and Locations

Study Contact

Erlind Allkushi

CONTACT

2164440223

allkuse2@ccf.org

Mary Bilancini

CONTACT

2164448983

bilancm@ccf.org

Principal Investigator

Choon Hyuck D Kwon, MD, PhD

PRINCIPAL_INVESTIGATOR

The Cleveland Clinic

Study Locations (Sites)

Cleveland Clinic

Cleveland, Ohio, 44195

United States

Collaborators and Investigators

Sponsor: Choon Hyuck David Kwon

Choon Hyuck D Kwon, MD, PhD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-29

Study Completion Date2027-07

Study Record Updates

Study Start Date2024-10-29

Study Completion Date2027-07

Terms related to this study

Keywords Provided by Researchers

Living Donor Liver Transplant
Liver Transplant Complications

Additional Relevant MeSH Terms

Liver Transplant